Inverness, Standard Diagnostics deal

Inverness began its second tender offer to acquire an additional 1.3 million (18.8%) shares of Standard Diagnostics at KRW40,000 per share or KRW51.8 billion ($44.1 million). The price is a 10.8% prem...